Indian resuscitation council (IRC) suggested guidelines for comprehensive cardiopulmonary life support (CCLS) for suspected or confirmed coronavirus disease (COVID-19) patient

Baljit Singh, Rakesh Garg, S S C Chakra Rao, Syed M Ahmed, JV Divatia, TV Ramakrishnan, Lalit Mehdiratta, Muralidhar Joshi, Naveen Malhotra, Sukhminder Jit Singh BajwaIndian Journal of Anaesthesia 2020 64(14):91-96 Management of the recent outbreak of the novel coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) remains challenging. The challenges are not only limited to its preventive strategies, but also extend to curative treatment, and are amplified during the management of critically ill patients with COVID-19. Older persons with comorbidities like diabetes mellitus, cardiac diseases, hepatic impairment, renal disorders and respiratory pathologies or immune impairing conditions are more vulnerable and have a higher mortality from COVID-19. Earlier, the Indian Resuscitation Council (IRC) had proposed the Comprehensive Cardiopulmonary Life Support (CCLS) for management of cardiac arrest victims in the hospital setting. However, in patients with COVID-19, the guidelines need to be modified,due to various concerns like differing etiology of cardiac arrest, virulence of the virus, risk of its transmission to rescuers, and the need to avoid or minimize aerosolization from the patient due to various interventions. There is limited evidence in these patients, as the SARS-CoV-2 is a novel infection and not much literature is available with high-level evidence related to CPR in patients of COVID-19. These suggested guidelines a...
Source: Indian Journal of Anaesthesia - Category: Anesthesiology Authors: Source Type: research

Related Links:

County commissioners told the Pittsburgh Business Times and other media outlets last week that they were told to expect targeted mitigation measures by Thursday.
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Medical College of Wisconsin president and CEO Dr. John Raymond Sr. called “very troubling” the recent increase in new Covid-19 cases in Wisconsin, but said lagging indicators of the disease’s impact like hospitalizations and deaths are not alarming so far. The number of new diagnoses in Wisconsin jumped in recent days after a lull following the Fourth of July. Wisc onsin posted its four highest days for new cases from July 9 through Sunday ranging from 752 to 929. “Our early indicators…
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
An Austin company has created a device that can measure someone's heart beat without any physical contact. The race is on to bring the product to market as the world deals with the coronavirus pandemic. Click through to learn more about their latest partnership.
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
A biopharmaceutical company that has been working in collaboration with UAB on an intranasal Covid-19 vaccine candidate said preclinical studies of the candidate had positive results. Altimmune Inc., a Gaithersburg, Maryland-based firm, said the results showed strong neutralizing activity and potent immunity in the respiratory tract. The nasal injection in the respiratory tract may be necessary to block both infection and transmission of the virus and prevent further spread.  Based on the findings,…
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
The mayor wants to avoid more restrictions on business, but that will depend on whether Covid-19 cases keep rising.
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Cases rise by over 230,000 worldwide in 24 hours; 250,000 people in Manila to return to lockdown; Brazil cases near 2m‘Compelling’ evidence air pollution worsens coronavirus – studyGerman study finds low Covid-19 infection rate in schoolsFauci sidelined as Trump ’s White House steps up briefing campaignBereaved urge EU chief to supervise Italian coronavirus inquiry7.57pmBSTThe Trump administration is increasinglyat war with Anthony Fauci, the federal government ’s top public health expert, over the handling of the epidemic, as the US continues to report around 60,000 new cases a day.In what ap...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news US news UK news Australia news South Africa Brazil Science Infectious diseases Source Type: news
Conclusion: So far no pharmacological intervention was proven effective and safe to warrant its use in the routine treatment of COVID-19 patients; therefore such patients should ideally be treated in the context of clinical trials. The recommendations herein provided will be revised continuously aiming to capture newly generated evidence.
Source: Revista Brasileira de Terapia Intensiva - Category: Intensive Care Source Type: research
CONCLUSIONS: SARS-Cov-2 has emerged as a worldwide threat, currently affecting 170 countries and territories across the globe. There is still much to be understood regarding SARS-CoV-2 about its virology, epidemiology and clinical management strategies; this knowledge will be essential to both manage the current pandemic and to conceive comprehensive measures to prevent such outbreaks in the future. PMID: 32495923 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
This study provides the largest overview of autopsies of SARS-CoV-2-infected patients presented so far.
Source: International Journal of Legal Medicine - Category: Medical Law Source Type: research
Ever since its outbreak in December 2019, novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to more than 200 nations, affecting over 509,000 individuals and inflicting over 23,000 fatalities globally [1]. Although the overall mortality rate is low, ranging from 1.4%-7.2%, people with diabetes mellitus (DM) tend to have more severe disease, acute respiratory distress syndrome and increased fatality [2,3]. Of the 1099 confirmed COVID-19 patients reported from China, 173 had severe disease; DM was more prevalent in those with severe disease (16.2%) as compa...
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Tags: Commentary Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | Coronavirus | COVID-19 | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Hospitals | India Health | Outbreaks | Respiratory Medicine | SARS